BC-11 hydrobromide

We are open as normal during COVID-19 pandemic. Order online, same day shipping out from North Carolina, USA

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 565139

CAS#: 443776-49-6

Description: BC-11 hydrobromide is an inhibitor of Urokinase-Plasminogen Activator (uPa) which induces additional impairment of mitochondrial activity, the production of reactive oxygen species, and promotion of apoptosis.

Price and Availability

Size Price Shipping out time Quantity
1mg USD 230 2 Weeks
5mg USD 465 2 Weeks
Inquire bulk and customized quantity

Pricing updated 2020-10-19. Prices are subject to change without notice.

BC-11 hydrobromide, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data, and MSDS documents are available in one week after order is received.

Chemical Structure


Theoretical Analysis

MedKoo Cat#: 565139
Name: BC-11 hydrobromide
CAS#: 443776-49-6
Chemical Formula: C8H12BBrN2O2S
Exact Mass: 289.9896
Molecular Weight: 290.97
Elemental Analysis: C, 33.02; H, 4.16; B, 3.72; Br, 27.46; N, 9.63; O, 11.00; S, 11.02

Synonym: BC11 hydrobromide; BC-11 hydrobromide; BC 11 hydrobromide; BC-11 HBr

IUPAC/Chemical Name: (4-((Carbamimidoylthio)methyl)phenyl)boronic acid hydrobromide


InChi Code: InChI=1S/C8H11BN2O2S.BrH/c10-8(11)14-5-6-1-3-7(4-2-6)9(12)13;/h1-4,12-13H,5H2,(H3,10,11);1H


Technical Data

Solid powder

>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Soluble in DMSO

Shelf Life:
>3 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:


1: Longo A, Librizzi M, Chuckowree IS, Baltus CB, Spencer J, Luparello C. Cytotoxicity of the Urokinase-Plasminogen Activator Inhibitor Carbamimidothioic Acid (4-Boronophenyl) Methyl Ester Hydrobromide (BC-11) on Triple-Negative MDA-MB231 Breast Cancer Cells. Molecules. 2015 May 28;20(6):9879-89. doi: 10.3390/molecules20069879. PubMed PMID: 26029857; PubMed Central PMCID: PMC6272237.